Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK1004723 and GSK835726 in Seasonal Allergic Rhinitis
NCT00972504Phase 2Completed
- Sponsor
- GSK
- Start
- Jun 2009
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of GSK-1004723, GSK835726 in seasonal allergic rhinitis (SAR), sponsored by GSK. Started Jun 2009; status: completed.
02
Drugs
GSK-1004723GSK835726
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00972504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00972504.